133 related articles for article (PubMed ID: 6170196)
1. [Natural antibodies against Pseudomonas aeruginosa in human gamma globulin preparations].
Chekan LV; Min'ovich FL; Kutimova LR; Edvabnaia LS; Stanislavskiĭ ES
Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):85-9. PubMed ID: 6170196
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of the antibody concentration and protective activity against Pseudomonas aeruginosa of gamma-globulin and IgM-enriched immunoglobulin preparations].
Kiseleva IA; Kandiurina VG; Timofeeva GV
Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):68-71. PubMed ID: 2424197
[TBL] [Abstract][Full Text] [Related]
3. A polyvalent human gamma-globulin immune to Pseudomonas aeruginosa: passive protection of mice against lethal infection.
Fisher MW
J Infect Dis; 1977 Aug; 136 Suppl():S181-5. PubMed ID: 70492
[TBL] [Abstract][Full Text] [Related]
4. [Antibodies against Pseudomonas aeruginosa toxin in preparations of normal human immunoglobulin].
Ianishevskaia MN; Kuz'mina NS; Kutimova LR; Lents MN; Minakova LV
Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):100-3. PubMed ID: 6412489
[TBL] [Abstract][Full Text] [Related]
5. Serologic and protective cross-reactivity of antisera to Pseudomonas aeruginosa extracellular slime glycolipoprotein.
Yushkova NA; Kholodkova EV; Korobova TS; Stanislavsky ES
Acta Microbiol Hung; 1986; 33(2):147-56. PubMed ID: 3101393
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study of the dynamics of the formation of protective antibodies to the antigens of the slime of Pseudomonas aeruginosa].
Iushkova NA; Stanislavskiĭ ES; Landsman NM
Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):78-83. PubMed ID: 6405564
[TBL] [Abstract][Full Text] [Related]
7. [The protective activity of 2 normal immunoglobulin preparations for intravenous administration in experimental Pseudomonas aeruginosa infection].
Vasilev ChL; Veleva KV; Tekelieva RKh; Pencheva PI
Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):54-6. PubMed ID: 1907793
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the protective properties of antisera and immunoglobulin to antigens of Pseudomonas aeruginosa slime].
Zaĭdner IG; Stanislavskiĭ ES; Gladus MA
Zh Mikrobiol Epidemiol Immunobiol; 1980 Oct; (10):52-7. PubMed ID: 6778023
[TBL] [Abstract][Full Text] [Related]
9. Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa.
Mates A; Zand P
J Hyg (Lond); 1974 Aug; 73(1):75-84. PubMed ID: 4213979
[TBL] [Abstract][Full Text] [Related]
10. [Hemagglutination titer of gamma-globulin preparations for intravenous use against OEP (original endotoxin protein), protease and elastase of Pseudomonas aeruginosa (author's transl)].
Yamashita N; Jozaki K; Iwata S; Iwasaki Y; Sunakawa K
Kansenshogaku Zasshi; 1981 Sep; 55(9):637-41. PubMed ID: 6172525
[No Abstract] [Full Text] [Related]
11. Passive hemagglutination reaction using formalinized sheep erythrocytes treated with tannic acid and coated with exotoxin of Pseudomonas aeruginosa.
Takeshi K; Homma JY
Jpn J Exp Med; 1978 Dec; 48(6):497-501. PubMed ID: 108439
[TBL] [Abstract][Full Text] [Related]
12. [Advisability of using donor blood immunoglobulin preparations for treating infections caused by Pseudomonas aeruginosa].
Nazarchuk LV
Klin Khir (1962); 1991; (1):23-4. PubMed ID: 1712409
[TBL] [Abstract][Full Text] [Related]
13. [Polish preparations for preventing and treating infections caused by Pseudomonas aeruginosa].
Schiller B; Buchowicz I; Lysakowska E; Sakiel S; Korbecki M
Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):30-2. PubMed ID: 2409720
[TBL] [Abstract][Full Text] [Related]
14. [The differentiation of OEP-HA titer between gamma-globulin products for intravenous use and their effectiveness in the passive protection of mice against Pseudomonas aeruginosa infection (author's transl)].
Haranaka K; Satomi N; Matsuo M; Fukaya K; Kunii O; Mashimo K
Kansenshogaku Zasshi; 1978 Nov; 52(11):490-6. PubMed ID: 85678
[No Abstract] [Full Text] [Related]
15. [Evaluation of the specific activity of hyperimmune anti-Pseudomonas aeruginosa human plasma in an experiment].
Podgornaia LG; Shinkarenko AA; Krokhina MA; Dziuban NF; D'iachenko VF
Patol Fiziol Eksp Ter; 1987; (2):70-2. PubMed ID: 3112715
[No Abstract] [Full Text] [Related]
16. [Use of a polyvalent erythrocyte diagnostic agent for determining antibodies to Pseudomonas aeruginosa in clinical practice].
Aleksandrova IA; Titova TI; Aleksandrov AD; Moroz AF
Zh Mikrobiol Epidemiol Immunobiol; 1989 Jan; (1):46-50. PubMed ID: 2496541
[TBL] [Abstract][Full Text] [Related]
17. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. II. Opsonic, agglutinative, and protective capacities of immunoglobulin G anti-Pseudomonas antibodies.
Bjornson AB; Michael JG
Infect Immun; 1972 May; 5(5):775-82. PubMed ID: 4629252
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of human gamma-globulin preparation in experimental pseudomonas aeruginosa infections in mice and its mode of action.
Kamimura T
Arzneimittelforschung; 1984; 34(11):1528-34. PubMed ID: 6084512
[TBL] [Abstract][Full Text] [Related]
19. Role of antibody in infections due to Pseudomonas aeruginosa.
Young LS
J Infect Dis; 1974 Nov; 130 Suppl(0):S111-8. PubMed ID: 4213568
[No Abstract] [Full Text] [Related]
20. Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay.
Pollack M; Taylor NS
J Clin Microbiol; 1977 Jul; 6(1):58-61. PubMed ID: 407250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
